收藏 分享(赏)

微RNA133和心肌肥厚钙调磷酸酯酶控制的相互抑制(英文).ppt

上传人:微传9988 文档编号:2445094 上传时间:2018-09-17 格式:PPT 页数:26 大小:2.26MB
下载 相关 举报
微RNA133和心肌肥厚钙调磷酸酯酶控制的相互抑制(英文).ppt_第1页
第1页 / 共26页
微RNA133和心肌肥厚钙调磷酸酯酶控制的相互抑制(英文).ppt_第2页
第2页 / 共26页
微RNA133和心肌肥厚钙调磷酸酯酶控制的相互抑制(英文).ppt_第3页
第3页 / 共26页
微RNA133和心肌肥厚钙调磷酸酯酶控制的相互抑制(英文).ppt_第4页
第4页 / 共26页
微RNA133和心肌肥厚钙调磷酸酯酶控制的相互抑制(英文).ppt_第5页
第5页 / 共26页
点击查看更多>>
资源描述

1、Reciprocal Repression between MicroRNA-133 and Calcineurin Controls Cardiac Hypertrophy: A Novel Mechanism for Progressive Cardiac Hypertrophy,De-Li Dong, Yan-Jie Lu, Bao-Feng Yang (董德利 吕延杰 杨宝峰)Department of Pharmacology Harbin Medical University, P.R.China,Aug.20-22,2009.Dalian,Background,Calcineur

2、in/NFAT pathway induces Cardiac Hypertrophy Calcineurin activation in cardiac hypertrophy Decreased miR-133 expression in cardiac hypertrophy Overexpression of miR-133 inhibits cardiac hypertrophy Inhibition of miR-133 induces cardiac hypertrophy,Aug.20-22,2009.Dalian,1. Calcineurin-Dependent Cardia

3、c Hypertrophy,Jeffery D. Molkentin et al. Cell,1998; 93,215228.,Aug.20-22,2009.Dalian,1. Calcineurin-Dependent Cardiac Hypertrophy,Jeffery D. Molkentin et al. Cell,1998; 93,215228.,Aug.20-22,2009.Dalian,1.Calcineurin-Dependent Cardiac Hypertrophy,Jeffery D. Molkentin et al. Cell,1998; 93,215228.,Aug

4、.20-22,2009.Dalian,Overexpression of calcineurin in mouse causes sudden cardiac death associated with decreased density of K channels,Deli Dong. et al. Cardiovascular Research 57 (2003) 320332,Aug.20-22,2009.Dalian,2. Calcineurin Activation in cardiac hypertrophy,Hae W. Lim et al.Circulation. 2000;1

5、01:2431-2437.,Aug.20-22,2009.Dalian,3. Calcineurin/NFAT Coupling Participates in Pathological, but not Physiological, Cardiac Hypertrophy,Wilkins BJ, et al. Circ Res. 2004;94:110-118.,Aug.20-22,2009.Dalian,Car A et al. Nat Med. 2007;13(5):613-8.,4. Decreased miR-133 expression in cardiac hypertrophy

6、,Aug.20-22,2009.Dalian,5. Overexpression of miR-133 inhibits cardiac hypertrophy,Car A et al. Nat Med. 2007;13(5):613-8.,Aug.20-22,2009.Dalian,6. Inhibition of miR-133 induces cardiac hypertrophy,Car A et al. Nat Med. 2007;13(5):613-8.,Aug.20-22,2009.Dalian,Hypothesis: Interaction between miR-133 an

7、d calcineurin in cardiac hypertrophy?, Calcineurin is the target of miR-133; The expression of miR-133 is regulated by calcineurin/NFAT signaling pathway.,Calcineurin,miR-133,Cardiac hypertrophy,Aug.20-22,2009.Dalian,Results 1. miR-133 Targets Calcineurin,Figure 1. Post-transcriptional Repression of

8、 Calcineurin by miR-133. (A) The sequences showing the unique sites of miRNA:mRNA complementary between miR-133 and calcineurin for rat and mouse genes. (B) Co-transfection of miR-133 with the luciferase reporter gene linked to the 3UTR of calcineurin reduced luciferase activity in rat and mouse spe

9、cies. *P0.01 vs Control; # P0.05 vs miR-133.,0,0.5,1.0,Relative luciferase activity,0,0.5,1.0,NC,miR-133,+AMO-133,miR-133,AMO-133,Mut-133,*,#,#,*,B,Mouse (n=8),Rat (n=10),A,Aug.20-22,2009.Dalian,Results: miR-133 Targets Calcineurin,Fig.2. (A) transfection of miR-133 specifically increased miR-133 le

10、vel in cultured cardiomyocytes. *P0.01 vs non-transfection group. (B) The negative control (NC) had no effect on miR-133 level, but AMO-133 decreased miR-133 level. *P0.01 vs control (lipofectamine transfection agents). n=3.,A,B,Aug.20-22,2009.Dalian,Results: miR-133 Targets Calcineurin,Fig.3. Effec

11、ts of miR-133 on calcineurin protein levels (n=5), mRNA level (n=5) and cell area (The number was in brackets) in normal cultured cardiomyoctes. *P0.01 vs Control.,Aug.20-22,2009.Dalian,A,B,C,1. miR-133 Targets Calcineurin,Figure 4. Effects of miR-133 on calcineurin protein levels (n=5), mRNA level

12、(n=5) and cell area (The number of cells was in brackets) in cardiomyoctes treated with PE (50M).,A,B,C,Aug.20-22,2009.Dalian,Results: Calcineurin/NFAT Signaling Regulates miR-133 Expression,Fig.5. Calcineurin inhibitor CsA inhibited cardiac hypertrophy induced by transverse aortic constriction in m

13、ice.,Sham,TAC,TAC+CsA,Aug.20-22,2009.Dalian,A,B,Results: Calcineurin/NFAT Signaling Regulates miR-133 Expression,Fig.6. Calcineurin inhibitor CsA inhibited cardiac hypertrophy (The number was in brackets), calcineurin expression (n=5) and activity (n=5). *P0.01 vs Control; #P0.01 vs TAC.,Aug.20-22,2

14、009.Dalian,A,B,C,Results: Calcineurin/NFAT Signaling Regulates miR-133 Expression,Fig.7. CsA restored the decreased miR-133 expression but not the increased miR-195 expression in TAC-induced hypertrophic heart. *P0.01 vs Control. # P0.01 vs TAC; n=5.,Aug.20-22,2009.Dalian,A,B,Results: Calcineurin/NF

15、AT Signaling Regulates miR-133 Expression,Fig.8. Primary rats cardiomyocytes in serum-free medium were stimulated with PE and PE+CsA. Cardiomyocytes were identified with a-actinin antibody (red signal) and nuclei were stained with bis-benzamide (blue).,Control,PE,PE+CsA,Aug.20-22,2009.Dalian,A,B,Res

16、ults: Calcineurin/NFAT Signaling Regulates miR-133 Expression,Fig.9. CsA inhibited hypertrophy (The number was in brackets), calcineurin expression (n=5) and activity (n=5) in cardiomyocytes treated with PE (50M). *P0.01 vs Control. # P0.01 vs PE.,Aug.20-22,2009.Dalian,A,B,C,Results: Calcineurin/NFA

17、T Signaling Regulates miR-133 Expression,Fig.10. CsA alleviated the decreased miR-133 expression in PE-treated cardiomyocyes. *P0.01 vs Control. #P0.05 vs PE; n=5.,Aug.20-22,2009.Dalian,Results: Calcineurin/NFAT Signaling Regulates miR-133 Expression,Fig.11. Calcineurin/NFAT-dependent Regulation of

18、miR-133. (A) Antisense-A ODNs increased the expression of miR-133 in cultured cardiomyocytes. *P0.01 vs Control; n=4. (B) NFAT decoy ODNs increased the expression of miR-133 in cultured cardiomyocytes. *P0.01 vs Control; n=5.,Aug.20-22,2009.Dalian,Conclusion:,Aug.20-22,2009.Dalian,Chang Chen, Rong Huo, Ning Wang, Zhe Li, Yu-Jie Tu,Acknowledgments,Jun-Tao Hu, Xia Chu, Wei Huang, Yan-Jie Lu Bao-Feng Yang,Aug.20-22,2009.Dalian,Thank you,

展开阅读全文
相关资源
猜你喜欢
相关搜索

当前位置:首页 > 医学治疗 > 基础医学

本站链接:文库   一言   我酷   合作


客服QQ:2549714901微博号:道客多多官方知乎号:道客多多

经营许可证编号: 粤ICP备2021046453号世界地图

道客多多©版权所有2020-2025营业执照举报